相关实验视频

Updated: Jul 13, 2025

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

作为肝细胞癌的潜在治疗点的曼诺斯结合性莱克2:多组学分析和实验验证

Hangyu Liao¹, Jun Yang¹, Yuyan Xu¹

¹General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510000, China.

|October 14, 2023

概括

曼诺酶结合性莱克2 (MBL2) 通过抑制扩散和转移来抑制肝细胞癌 (HCC) 的进展. 由miR-34c-3p驱动的MBL2的下调与HCC预后不佳相关,这表明MBL2是治疗点.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

曼诺结合性莱克2 (MBL2) 参与免疫调节和瘤发育.
MBL2基因多态性与各种癌症风险有关,包括肝细胞癌 (HCC).
目前尚不清楚MBL2在HCC发病过程中的特定功能.

研究的目的:

研究MBL2作为HCC中关键调节者的作用.
确定MBL2是否是HCC的潜在治疗点.
阐明MBL2在HCC中的功能背后的分子机制.

主要方法:

生物信息学分析以确定MBL2表达,瘤途径和微环境之间的相关性.
在体外测试 (细胞计数套件-8,殖民地形成,穿孔迁移,伤口愈合) 来评估MBL2过度表达对HCC细胞的影响.
双露西法酶记者测定证实了miR-34c-3p和MBL2.p之间的调节关系.

主要成果:

在HCC中,MBL2下调与促进瘤通路和免疫抑制微环境有关.
在HCC患者中较低的MBL2表达与不良预后相关.
过度表达MBL2抑制了HCC细胞的增殖和转移.
确定miR-34c-3p是MBL2表达的调节者,影响HCC进展.

结论:

通过抑制扩散和转移,MBL2在HCC发育中发挥着重要作用.
在HCC中,miR-34c-3p/MBL2轴代表了一个新的调节机制.
MBL2和miR-34c-3p是改善HCC治疗结果的潜在治疗点.

关键词:

肝细胞癌是肝细胞癌.免疫调节免疫调节曼诺糖结合性莱克 2 2 在 miR-34c-3p 中使用.瘤微环境是一个微环境.

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Selectins

Selectins

Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...